FDA Inspection
Biomat USA, IncBiomat USA, Inc – FDA Inspection, Mar 16, 2012
Record Details
This FDA Inspection record concerns Biomat USA, Inc, with an inspection on March 16, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc
- Inspection Date
- March 16, 2012
- Product Type
- Biologics
View Company Profile
ID · 02421087-51af-4e8f-a87b-fe84a720ce90
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 774405
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(c)Thorough investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 13, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc
- FDA Inspection 1169082 - 2022-04-21
- FDA Inspection 1000746 - 2017-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.